Target intelligence / Profile preview

RYK pseudogene 1 (RYKP1)

Target
RYKP1
Molecular classification
Other (Pseudogene)
01

Overview

RYK pseudogene 1 (RYKP1) is a human pseudogene related to the functional gene RYK (Receptor-like tyrosine kinase)[5]. Pseudogenes are non-functional segments of DNA that resemble functional genes but typically do not produce functional proteins. RYKP1 has aliases such as JTK5, RYKL1, and JTK5B, and has been cataloged in genome databases (e.g., HGNC:10482, Ensembl:ENSG00000263219)[5]. As a pseudogene, it is not implicated as a therapeutic or pharmacological target and has no known direct biological or disease-related function.

Other names
JTK5RYKL1JTK5BRYKP

Beyond the preview

Go deeper on RYK pseudogene 1 (RYKP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RYK pseudogene 1 (RYKP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call